Core Laboratories Inc
CLB
Market Cap$503.99M
Close$
$6.28
42.7% downside
Current Fair Value
42.7% downsideOvervalued by 42.7% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $503.99 Million |
|---|---|
| Enterprise Value | $525.87 Million |
| Dividend Yield | $0.04 (0.372093023255814%) |
| Earnings per Share | $0.67 |
| Beta | 1.45 |
| Outstanding Shares | 46,773,000 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 17.94 |
|---|---|
| PEG | -17.12 |
| Price to Sales | 1.0 |
| Price to Book Ratio | 2.19 |
| Enterprise Value to Revenue | 1.02 |
| Enterprise Value to EBIT | 10.22 |
| Enterprise Value to Net Income | 18 |
| Total Debt to Enterprise | 0.08 |
| Debt to Equity | 0.17 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Core Laboratories N.V.
4,700 employeesCore Laboratories N.V. is a leading provider of proprietary and patented reservoir description and production enhancement services and products used to optimize petroleum reservoir performance. The Company has over 70 offices in more tha...